Graphical Elicitation of a Prior Distribution for a Clinical Trial
Journal of the Royal Statistical Society Series D (The Statistician)Published 1 January 1993Open access
Kathryn Chaloner, Timothy R. Church, Thomas A. Louis, John P. Matts
Citations107
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A method to help quantify beliefs in the form of a prior distribution about regression coefficients in a proportional hazards regression model is described, developed for a randomized trial comparing prophylaxes for toxoplasmosis in a population of HIV-positive individuals.
Abstract
Kathryn Chaloner, Timothy Church, Thomas A. Louis, John P. Matts, Graphical Elicitation of a Prior Distribution for a Clinical Trial, Journal of the Royal Statistical Society. Series D (The Statistician), Vol. 42, No. 4, Special Issue: Conference on Practical Bayesian Statistics, 1992 (1993), pp. 341-353
Keywords
Computer ScienceMathematics
Journal of the Royal Statistical Society Series B (Statistical Methodology)Non-Parametric Bayesian Analysis of Survival Time Data
373 Citations1978John D. Kalbfleisch
Journal of the American Statistical AssociationThe Assessment of Prior Distributions in Bayesian Analysis
354 Citations1967Robert L. Winkler
Journal of the American Statistical AssociationInteractive Elicitation of Opinion for a Normal Linear Model
292 Citations1980Joseph B. Kadane, James Dickey +3 more
Wiley series in probability and statisticsLISP‐STAT: An Object‐Oriented Environment for Statistical Computing and Dynamic Graphics
282 Citations1990Luke Tierney
AIDSToxoplasma gondii serology in HIV-infected patients
225 Citations1990Irene Grant, Jonathan Gold +3 more
Patients with HIV infection should be tested for antibody to T. gondii and monitored for any neurologic change, and methods of prophylaxis for CNS toxoplasmosis in these high-risk patients need to be developed.
Statistics in MedicineApplying Bayesian ideas in drug development and clinical trials
131 Citations1993David J. Spiegelhalter, Laurence S. Freedman +1 more
A variety of tools for assessing the current evidence for treatment efficacy are presented, making use of graphical display to provide insight into ethical and efficiency issues in starting and stopping trials.
Journal of the Royal Statistical Society Series D (The Statistician)Assessment of a Beta Prior Distribution: PM Elicitation
113 Citations1983Kathryn Chaloner, George T. Duncan
Statistical ScienceBiostatistics and Bayes
91 Citations1990Norman E. Breslow
Bayesian methods simplify the analysis of data from sequential clinical trials and avoid certain paradoxes of frequentist inference, and offer a natural setting for the synthesis of expert opinion in deciding policy matters.
Journal of the Royal Statistical Society Series B (Statistical Methodology)Quantifying Expert Opinion in Linear Regression Problems
74 Citations1988Paul H. Garthwaite, James Dickey
A method of assessing a subjective prior distribution for a normal linear sampling model is presented, designed to require elicitation tasks that people can perform competently and introduces a type of task not previously reported.
The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of MedicineProgress Toward a More Ethical Method for Clinical Trials
61 Citations1986Joseph B. Kadane
It is proposed that only admissible treatments, so defined, be allowed to be assigned to the patient, and the ethical and statistical consequences of this principle are explored.
Statistics in MedicineApplication of bayesian statistics to decision making during a clinical trial
45 Citations1992Laurence S. Freedman, David J. Spiegelhalter
The application of Bayesian methods to the monitoring and analysis of a trial of treatment for patients with advanced colorectal carcinoma is described and an upper boundary very close to the Pocock group sequential boundary is described.
The LancetToxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis
39 Citations1992Mark Z. Jacobson, Carroll Child +6 more
The clindamycin arm of the trial was prematurely terminated, although recruitment to the pyrimethamine arm continues.
Journal of the American Statistical AssociationStatistical Issues Arising in AIDS Clinical Trials
36 Citations1992Susan S. Ellenberg, Dianne M. Finkelstein +1 more
In the 11 years since AIDS became a defined disease, programs for the development and evaluation of new drugs for this disease have grown rapidly and statisticians have taken a leadership role in identifying and addressing important methodological issues in the evaluation of AIDS drugs.
Journal of the Royal Statistical Society Series D (The Statistician)Bayesian Approaches for Monitoring Clinical Trials with an Application to Toxoplasmic Encephalitis Prophylaxis
33 Citations1993Bradley P. Carlin, Kathryn Chaloner +3 more
Computational issues are investigated by comparing the posterior distributions of model parameters obtained assuming approximate posterior normality with more precise results obtained via numerical integration and the impact of approximations on the performance of Bayesian stopping rules.
The American StatisticianA Kalman-Filter Smoothing Approach for Extrapolations in Certain Dose–Response, Damage-Assessment, and Accelerated-Life-Testing Studies
25 Citations1987Richard J. Meinhold, Nozer D. Singpurwalla
Journal of Behavioral Decision MakingAn elicitation method for multiple linear regression models
23 Citations1991Paul H. Garthwaite, James Dickey
Opinion about the regression coefficients and experimental error is elicited and modeled by a multivariate probability distribution (a Bayesian conjugate prior distribution) and various assessment tasks are used to estimate its parameters.